In recent years, the production of recombinant pharmaceutical proteins in heterologous
systems has increased significantly. Most applications involve complex proteins and …

Plant-based systems are considered a valuable platform for the production of recombinant
proteins as a result of their well-documented potential for the flexible, low-cost production of …

The number of approaches to recombinant protein production in plants is greater than ever
before. Development of these new and improved technologies as production platforms for …

The market for biopharmaceuticals is dominated by recombinant proteins and is driven
mainly by the development of vaccines and antibodies. Manufacturing predominantly relies …

Molecular pharming is a cost-effective platform for the production of recombinant proteins in
plants. Although the biopharmaceutical industry still relies on a small number of …

Many different plant-based systems have been used to produce recombinant
pharmaceutical proteins but only a small number have made the leap from an experimental …

The demand for recombinant proteins in terms of quality, quantity, and diversity is increasing
steadily, which is attracting global attention for the development of new recombinant protein …

Plants have been used for more than 20 years to produce recombinant proteins but only
recently has the focus shifted away from proof-of-principle studies (ie is my protein …

The new generation of biological products are largely the result of genetic engineering. The
qualitative and quantitative demand for recombinant proteins is steadily increasing …

Protein-based biopharmaceuticals are often produced in mammalian cell cultures, which are
more expensive than microbial systems but capable of authentic post-translational …